AbCellera Biologics (ABCL) Q4 2024 Earnings

5NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.17
-0.15
-0.13
-0.11

Details

Expected EPS
-0.124444
Actual EPS
-0.17
Surprise EPS
-0.05
Surprise Percent
+36.61%

Description

AbCellera Biologics (ABCL) has reported earnings of -0.17 per share for Q4 2024.

0 Comments

Share your thoughts